A searchable metadata network graph for microbiome metabolomics

Read full text
Authors: Vincent Charron-Lamoureux, Shipei Xing, Abubaker Patan, Corinn Walker, Ricardo Almada-Monter, Yasin El Abiead, Haoqi Nina Zhao, Lucas Patel, Yuhan Weng, Antonio Gonzalez, Gail Ackermann, Victoria Deleray
+55 more V. Kalai Gandhi, Ipsita Mohanty, Andres Mauricio Caraballo Rodriguez, Kine Eide Kvitne, Simone Zuffa, Annabelle Norman, Anthony Martin, Loryn Chin, Rocío Paz-González, Marta Sala-Climent, Nadia Suryawinata, Jasmine Zemlin, Harsha Gouda, Zhewen Hu, Grant J. Norton, Prajit Rajkumar, Anthony J. A. Molina, Jaclyn Bergstrom, Monae Pinner, Sadie Giddings, Allegra T. Aron, Liang Liang, Samira Dahesh, Santosh Lamichhane, Erin R. Reilly, Victor Nizet, Anna E. Skrip, April L. Lukowski, Selene F. H. Shore, Subhomitra Ghoshal, Melinda Anne Engevik, Thomas D. Horvath, Simone Renwick, Julius Agongo, Maria L. Marco, Sarkis K. Mazmanian, M. C. Wang, Heejung Yang, Daniel McDonald, Monica Guma, Evi Stegmann, Naybel Hernandez Perez, Paolo Stincone, Eric M. Kemen, Abzer Kelminal Pakkir Shah, Lars Bode, Daniel Petras, Dionicio Siegel, Manuela Raffatellu, Andrew D. Patterson, Suzanne Devkota, Adrián Jinich, Rob Knight, Karsten Zengler, Pieter C. Dorrestein
Cited by: 3
References: 59

Abstract

Abstract Establishing the biological context of microbial metabolites remains a major challenge. We present microbiomeMASST, a metadata-driven network graph that maps metabolites across 467 available datasets with 144,424 mass spectrometry files from humans, animals, and microbial culture systems. MicrobiomeMASST integrates monocultures, synthetic communities, and host-associated samples across multiple body sites and plants. MS/MS spectra can be queried to trace occurrence across hosts, experimental conditions, and interventions, enabling cross-study integration. We demonstrate this framework by contextualizing microbial-conjugated bile acids and interrogating microbiome-mediated drug metabolism. Screening gut bacteria revealed deprolylation of the angiotensin-converting enzyme (ACE) inhibitor prodrug enalapril. Using microbiomeMASST, we traced this metabolite across human cohorts, microbial isolates, environmental samples, and in Gorilla gorilla . Structural modeling and enzymatic assays showed that microbial deprolylation abolishes ACE inhibition, thereby inactivating its therapeutic effect. Together, microbiomeMASST links MS/MS spectra to biological context, converting isolated observations into an interpretable microbiome map for cross-study analysis.

Fields of Study & Subjects

Metabolomics and Mass Spectrometry Studies Gut microbiota and health Microbial Metabolic Engineering and Bioproduction

Publication details

Journal / source
bioRxiv (Cold Spring Harbor Laboratory)
Publisher
openRxiv
Publication date
5 February 2026
Language
EN
Document type
Preprint